Institutional Ownership Silverback Therapeutics, Inc. (SBTX)
This table provides information about the institutional ownership of Silverback Therapeutics, Inc. (SBTX). We have compiled data on the 209 institutions that hold shares in the stock, with a total of 83.8 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Nov 14, 2025 Q3 2025 |
10,860,977
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
8,288,510
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 10.31%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
7,503,812
shares
|
$0
0.0% of portfolio
|
Q3 2025
Reduced 22.84%
|
|
|
Rubric Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
4,500,000
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 247.52%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,084,339
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 53.65%
|
|
|
Sr One Capital Management, LP
|
Nov 12, 2025 Q3 2025 |
4,012,903
shares
|
$0
0.0% of portfolio
|
Q1 2023
Added 33.33%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
3,500,303
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 7.28%
|
|
|
Abrdn PLC
|
Nov 06, 2025 Q3 2025 |
3,097,022
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 106.11%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
2,895,256
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 31.93%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
2,642,111
shares
|
$0
0.0% of portfolio
|
Q3 2025
Reduced 30.94%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
2,398,012
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 31.13%
|
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,600,000
shares
|
$0
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,586,033
shares
|
$0
0.0% of portfolio
|
Q3 2025
Reduced 29.26%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,505,617
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 12.16%
|
|
|
Southpoint Capital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,500,000
shares
|
$0
0.0% of portfolio
|
Q3 2025
Reduced 12.23%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,325,739
shares
|
$0
0.0% of portfolio
|
Q3 2025
Reduced 9.46%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
1,303,399
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 0.74%
|
|
|
Bamco Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,268,532
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 3071.33%
|
|
|
Janney Montgomery Scott LLC
|
Oct 27, 2025 Q3 2025 |
1,213,020
shares
|
$0
0.03% of portfolio
|
Q3 2025
Added 105.1%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
1,034,798
shares
|
$0
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
976,511
shares
|
$0
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
936,729
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 15.84%
|
|
|
Levin Capital Strategies, L.P.
New York, NY |
Nov 07, 2025 Q3 2025 |
764,294
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 164.33%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Nov 14, 2025 Q3 2025 |
756,347
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 12.32%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
700,414
shares
|
$0
0.0% of portfolio
|
Q3 2025
Added 82.58%
|
|